ReviewCurrent treatment options in oncology2024
Management of Paraneoplastic Syndromes in the Era of Immune Checkpoint Inhibitors.
Maxime Junior Jean et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it